Beyond analgesia: A comprehensive opinion review on the dual-action strategy of celecoxib and duloxetine in knee osteoarthritis
World Journal of Psychiatry · 19.08.2026 · 16 (8)
DOI: 10.5498/wjp.116224 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Psychiatry, online erschienen am 19.08.2026. Verfasst von Takahiko Nagamine. Die Arbeit nennt 63 Literaturangaben.
Abstract (Originalsprache)
Knee osteoarthritis is no longer viewed solely as a peripheral joint disease but as a complex biopsychosocial condition involving central sensitization and psychological distress. Recently, the combination of celecoxib (a cyclooxygenase-2 inhibitor) and duloxetine (a serotonin-norepinephrine reuptake inhibitor) has gained traction for addressing this “pain-depression-anxiety” triad. This opinion review evaluates the synergistic efficacy and antagonistic risks of dual-action therapy. We aim to move beyond short-term retrospective data to provide a long-term pharmacovigilance perspective. The combination offers superior analgesia and “opioid-sparing” potential by targeting both peripheral inflammation and descending inhibitory pathways. However, this synergy of efficacy is matched by a “synergy of toxicity”. Risks include exacerbated hypertension, increased gastrointestinal bleeding due to serotonin-platelet interactions, and a “fall-risk paradox” where drug-induced dizziness offsets the functional gains of pain relief. While promising for the “centralized-distressed” knee osteoarthritis phenotype, this regimen requires rigorous patient screening and a pre-defined exit strategy. Clinicians must balance the promise of psychological restoration against the formidable physiological risks of the aging patient.
Zitieren
APA
Nagamine, T. (2026). Beyond analgesia: A comprehensive opinion review on the dual-action strategy of celecoxib and duloxetine in knee osteoarthritis. World Journal of Psychiatry, 16(8). https://doi.org/10.5498/wjp.116224
Vancouver
Nagamine T. Beyond analgesia: A comprehensive opinion review on the dual-action strategy of celecoxib and duloxetine in knee osteoarthritis. World Journal of Psychiatry. 2026;16(8). doi:10.5498/wjp.116224
BibTeX
@article{Nagamine2026,
author = {Nagamine, Takahiko},
title = {Beyond analgesia: A comprehensive opinion review on the dual-action strategy of celecoxib and duloxetine in knee osteoarthritis},
journal = {World Journal of Psychiatry},
year = {2026},
volume = {16},
number = {8},
doi = {10.5498/wjp.116224}
}
EUVIMED